159 related articles for article (PubMed ID: 4950814)
1. Irreversibility in the post-transfusion phase of hemorrhagic shock.
Rush BF
Adv Exp Med Biol; 1971 Oct; 23(0):215-34. PubMed ID: 4950814
[No Abstract] [Full Text] [Related]
2. [Emergency therapy in manifested shock].
Bartels O
Fortschr Med; 1973 Jun; 91(18):777-80. PubMed ID: 4723861
[No Abstract] [Full Text] [Related]
3. Evolution of the modern therapy of shock: science vs. empiricism.
Schumer W
Surg Clin North Am; 1971 Feb; 51(1):3-13. PubMed ID: 5576172
[No Abstract] [Full Text] [Related]
4. Recent developments in the stuy and treatment of shock.
Baue AE
Surg Gynecol Obstet; 1968 Oct; 127(4):849-78. PubMed ID: 4877373
[No Abstract] [Full Text] [Related]
5. Irreversible shock.
Baraka A
Middle East J Anaesthesiol; 1982 Oct; 6(6):539-52. PubMed ID: 7183902
[No Abstract] [Full Text] [Related]
6. The "VIP" approach to the bedside management of shock.
Weil MH; Shubin H
JAMA; 1969 Jan; 207(2):337-40. PubMed ID: 5818156
[No Abstract] [Full Text] [Related]
7. Transient cardiac failure in haemorrhagic shock.
Knight RJ
Br J Anaesth; 1969 Apr; 41(4):352-6. PubMed ID: 5780741
[No Abstract] [Full Text] [Related]
8. [Pathogenesis and current treatment of shock studied from the aspects of the peripheral circulation and metabolism].
Hayashi S; Ishiyama K; Tamakuma M; Koizumi S; Nakayama N
Shujutsu; 1967 Dec; 21(12):1222-33. PubMed ID: 5598670
[No Abstract] [Full Text] [Related]
9. Intraoperative patient care. Fluid therapy.
Giesecke AH; Jenkins MT
Clin Anesth; 1976; 11(2):57-69. PubMed ID: 963875
[No Abstract] [Full Text] [Related]
10. [Recent advances concerning hemorrhagic shock. Clinical results with the use of high dosage of hydrocortisone].
Cattaneo AD; Agustoni R
Minerva Anestesiol; 1969 Oct; 35(10):1050-78. PubMed ID: 4919768
[No Abstract] [Full Text] [Related]
11. [Shock and its treatment wuth chemotherapeutic agents].
Fujita M; Iwabuchi K
Jibiinkoka; 1969 Oct; 40(10):843-50. PubMed ID: 5812656
[No Abstract] [Full Text] [Related]
12. Hypovolemic shock.
Olsen WR
Mich Med; 1972 Jan; 71(2):15-24. PubMed ID: 4551078
[No Abstract] [Full Text] [Related]
13. Hemorrhagic and endotoxic shock: a pathophysiologic approach to diagnosis and management.
Roberts JM; Laros RK
Am J Obstet Gynecol; 1971 Aug; 110(8):1041-9. PubMed ID: 4935087
[No Abstract] [Full Text] [Related]
14. Treatment of hemorrhagic shock with a new vasodilator.
Vick JA; Roberts CR; Heiffer MH; Caldwell RW; Nies A
Mil Med; 1973 Aug; 138(8):490-4. PubMed ID: 4147357
[No Abstract] [Full Text] [Related]
15. Treatment of shock.
Hardaway RM
Compr Ther; 1979 Mar; 5(3):14-25. PubMed ID: 445980
[TBL] [Abstract][Full Text] [Related]
16. Traumatic shock in man.
Moss GS; Saletta JD
N Engl J Med; 1974 Mar; 290(13):724-6. PubMed ID: 4205153
[No Abstract] [Full Text] [Related]
17. The dilemma of vasopressors and vasodilators in the therapy of shock.
Shoemaker WC; Brown RS
Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
[No Abstract] [Full Text] [Related]
18. An essay regarding pathogenesis and treatment of shock due to bacteremia with special reference to "gram-negative" shock.
Waisbren BA
Prog Cardiovasc Dis; 1967 Sep; 10(2):123-33. PubMed ID: 6048070
[No Abstract] [Full Text] [Related]
19. Fluid therapy and blood transfusions in small animals.
Larsen LH; Warren DF
Aust Vet J; 1971 Feb; 47(2):29-37. PubMed ID: 5102652
[No Abstract] [Full Text] [Related]
20. Heart failure and fluid loss in hemorrhagic shock.
Rothe CF
Fed Proc; 1970; 29(6):1854-60. PubMed ID: 5529887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
